Literature DB >> 22674855

Ligand binding by PDZ domains.

Celestine N Chi1, Anders Bach, Kristian Strømgaard, Stefano Gianni, Per Jemth.   

Abstract

The postsynaptic density protein-95/disks large/zonula occludens-1 (PDZ) protein domain family is one of the most common protein-protein interaction modules in mammalian cells, with paralogs present in several hundred human proteins. PDZ domains are found in most cell types, but neuronal proteins, for example, are particularly rich in these domains. The general function of PDZ domains is to bring proteins together within the appropriate cellular compartment, thereby facilitating scaffolding, signaling, and trafficking events. The many functions of PDZ domains under normal physiological as well as pathological conditions have been reviewed recently. In this review, we focus on the molecular details of how PDZ domains bind their protein ligands and their potential as drug targets in this context.
Copyright © 2012 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674855     DOI: 10.1002/biof.1031

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  18 in total

1.  Peptide Binding to a PDZ Domain by Electrostatic Steering via Nonnative Salt Bridges.

Authors:  Nicolas Blöchliger; Min Xu; Amedeo Caflisch
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

2.  Real-time observation of ligand-induced allosteric transitions in a PDZ domain.

Authors:  Olga Bozovic; Claudio Zanobini; Adnan Gulzar; Brankica Jankovic; David Buhrke; Matthias Post; Steffen Wolf; Gerhard Stock; Peter Hamm
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

3.  Efficient synthesis of CN2097 using in situ activation of sulfhydryl group.

Authors:  Shaban Darwish; Keykavous Parang; John Marshall; Dennis J Goebel; Rakesh Tiwari
Journal:  Tetrahedron Lett       Date:  2017-06-23       Impact factor: 2.415

4.  Designing of disruptor molecules to restrain the protein-protein interaction network of VANG1/SCRIB/NOS1AP using fragment-based drug discovery techniques.

Authors:  Suchandra Roy Acharyya; Plaboni Sen; Thirukumaran Kandasamy; Siddhartha Sankar Ghosh
Journal:  Mol Divers       Date:  2022-06-01       Impact factor: 2.943

5.  Cryptic binding properties of a transient folding intermediate in a PDZ tandem repeat.

Authors:  Francesca Malagrinò; Giuliana Fusco; Valeria Pennacchietti; Angelo Toto; Caterina Nardella; Livia Pagano; Alfonso de Simone; Stefano Gianni
Journal:  Protein Sci       Date:  2022-09       Impact factor: 6.993

6.  Human Serine Racemase Weakly Binds the Third PDZ Domain of PSD-95.

Authors:  Roberta Giaccari; Francesco Marchesani; Carlotta Compari; Emilia Fisicaro; Andrea Mozzarelli; Barbara Campanini; Stefano Bettati; Stefano Bruno; Serena Faggiano
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

Review 7.  RhoGEFs in cell motility: novel links between Rgnef and focal adhesion kinase.

Authors:  N L G Miller; E G Kleinschmidt; D D Schlaepfer
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

8.  Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.

Authors:  Anders Bach; Søren W Pedersen; Liam A Dorr; Gary Vallon; Isabelle Ripoche; Sylvie Ducki; Lu-Yun Lian
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

9.  Identification of β-strand mediated protein-protein interaction inhibitors using ligand-directed fragment ligation.

Authors:  Zsófia Hegedüs; Fruzsina Hóbor; Deborah K Shoemark; Sergio Celis; Lu-Yun Lian; Chi H Trinh; Richard B Sessions; Thomas A Edwards; Andrew J Wilson
Journal:  Chem Sci       Date:  2021-01-06       Impact factor: 9.825

10.  Tolerance of protein folding to a circular permutation in a PDZ domain.

Authors:  Greta Hultqvist; Avinash S Punekar; Angela Morrone; Celestine N Chi; Ake Engström; Maria Selmer; Stefano Gianni; Per Jemth
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.